Continuously monitor vital signs, including blood pressure, heart rate, and rhythm, for at least one hour post-administration. Observe for hypotension and bradycardia; these are common adverse effects.
ECG monitoring is crucial for detecting any arrhythmias. Pay close attention to the QRS complex duration and PR interval for signs of conduction delays or AV block. Adjustments to the infusion rate may be necessary based on ECG findings.
Assess the patient’s mental status. Look for signs of dizziness, lightheadedness, or confusion–these indicate potential adverse reactions to the medication. Report any significant changes to the attending physician immediately.
Maintain intravenous access. This allows for rapid administration of supportive medications should adverse effects occur. Be prepared to administer atropine for bradycardia or fluids for hypotension.
Document all observations, including vital signs, ECG findings, and any reported symptoms, meticulously. This detailed record assists in ongoing patient care and informs future treatment decisions.
Closely watch for signs of heart failure exacerbation, such as shortness of breath, edema, and reduced urine output. Report any worsening symptoms without delay.
Remember: This information is for guidance only and does not replace professional medical judgment. Always follow institutional protocols and consult with your supervising physician or nurse practitioner for specific instructions.
